½Å°æ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå º¸°í¼­ : µ¿Çâ, ¿¹Ãø ¹× °æÀï ºÐ¼®(-2030³â)
Neurological Biomarker Market Report: Trends, Forecast and Competitive Analysis to 2030
»óǰÄÚµå : 1597240
¸®¼­Ä¡»ç : Lucintel
¹ßÇàÀÏ : 2024³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,850 £Ü 7,017,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,800 £Ü 8,392,000
PDF (2 Users License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 2¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,700 £Ü 9,694,000
PDF (5 Users License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,850 £Ü 12,805,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ ±â¾÷ ³» ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, ±¹³»¿¡ ÀÖ´Â »ç¾÷À常 ÇØ´çµÇ¸ç, ÇØ¿Ü ÁöÁ¡ µîÀº Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

½Å°æ ¹ÙÀÌ¿À¸¶Ä¿ µ¿Çâ ¹× Àü¸Á

¼¼°è ½Å°æ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö 11.7%ÀÇ CAGRÀ» ±â·ÏÇϸç 2030³â±îÁö ¾à 147¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ¾×ü »ý°ËÀÇ Ã¤Åà Ȯ´ë, ½Å°æ ¹ÙÀÌ¿À¸¶Ä¿ °³¹ß¿¡ ÀΰøÁö´É(AI)ÀÇ È°¿ë È®´ë, ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µîÀÔ´Ï´Ù. ¼¼°è ½Å°æ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀÇ ¹Ì·¡´Â º´¿ø ¹× º´¿ø ¿¬±¸¼Ò, µ¶¸³ ÀÓ»óÁø´Ü¼¾ÅÍ, ¿¬±¸±â°ü ½ÃÀå¿¡¼­ÀÇ ±âȸ·Î ÀÎÇØ À¯¸ÁÇÑ ½ÃÀåÀ¸·Î Àü¸ÁµÇ°í ÀÖ½À´Ï´Ù.

½Å°æ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀÇ Àü·«Àû ¼ºÀå ±âȸ

½Å°æ ¹ÙÀÌ¿À¸¶Ä¿ÀÇ Àü·«Àû ¼ºÀå ±âȸ´Â ¿©·¯ ÀÀ¿ë ºÐ¾ß¿¡ °ÉÃÄ ³ªÅ¸³ª°í ÀÖ½À´Ï´Ù. ÀÌ´Â ±â¼ú ¹ßÀü¿¡¼­ Áø´Ü ¹× Ä¡·á Á¢±Ù¹ý °³¼±¿¡ ÃÊÁ¡À» ¸ÂÃá °Í±îÁö ´Ù¾çÇϸç, ½Å°æ ÁúȯÀÇ °ü¸®»Ó¸¸ ¾Æ´Ï¶ó ½ÃÀå È®´ëÀÇ °¡´É¼ºÀ» Á¦°øÇÕ´Ï´Ù.

ÀÌ·¯ÇÑ Àü·«Àû ¼ºÀå ±âȸ´Â Çõ½ÅÀûÀÎ Áø´Ü ¹× Ä¡·á Á¢±Ù¹ýÀ» ÃËÁøÇÔÀ¸·Î½á ½Å°æ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¾ËÃ÷ÇÏÀ̸Ӻ´, ÆÄŲ½¼º´, ´Ù¹ß¼º °æÈ­Áõ, ³úÁ¹Áß, ½Å°æ¿°Áõ¿¡ ´ëÇÑ °ü½ÉÀº ½Å°æÁúȯ °ü¸®¸¦ °³¼±Çϱâ À§ÇØ °³ÀÎÈ­µÈ Ä¡·á ¿É¼Ç°ú °ü·ÃµÈ ´õ ³ªÀº ¹ÙÀÌ¿À¸¶Ä¿ °³¹ßÀ» À§ÇÑ ÁøÀüÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½Å°æ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀÇ ÃËÁø¿äÀÎ ¹× °úÁ¦

½Å°æ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¸î °¡Áö ÁÖ¿ä ÃËÁø¿äÀΰú °úÁ¦°¡ ÀÖ½À´Ï´Ù. ±â¼úÀû Áøº¸, °æÁ¦Àû ¿äÀÎ, ±ÔÁ¦Àû °í·Á»çÇ×Àº ½ÃÀå ¿ªÇп¡ Å« ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ÃËÁø¿äÀÎÀº ¼ºÀå°ú Çõ½ÅÀ» µÞ¹ÞħÇÏ´Â ¹Ý¸é, ½Å°æ ¹ÙÀÌ¿À¸¶Ä¿ÀÇ ÀáÀç·ÂÀ» ÃæºÐÈ÷ ½ÇÇöÇϱâ À§Çؼ­´Â ºñ¿ë, ±ÔÁ¦ ¹× ±â¼ú ÅëÇÕ°ú °ü·ÃµÈ °úÁ¦¸¦ ±Øº¹ÇØ¾ß ÇÕ´Ï´Ù.

½Å°æ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀ» ÁÖµµÇÏ´Â ¿äÀÎÀº ´ÙÀ½°ú °°½À´Ï´Ù.

½Å°æ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀÇ °úÁ¦´Â ´ÙÀ½°ú °°½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ ½Å°æ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå : ½ÃÀå ¿ªÇÐ

Á¦3Àå 2018³âºÎÅÍ 2030³â±îÁö ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼®

Á¦4Àå 2018³âºÎÅÍ 2030³â±îÁö Áö¿ªº° ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼®

Á¦5Àå °æÀï ºÐ¼®

Á¦6Àå ¼ºÀå ±âȸ¿Í Àü·« ºÐ¼®

Á¦7Àå ÁÖ¿ä ±â¾÷ °³¿ä

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Neurological Biomarker Trends and Forecast

The future of the global neurological biomarker market looks promising with opportunities in the hospital & hospital laboratory, independent clinical diagnostic center, and research organizations markets. The global neurological biomarker market is expected to reach an estimated $14.7 billion by 2030 with a CAGR of 11.7% from 2024 to 2030. The major drivers for this market are the growing adoption of liquid biopsy, increasing utilization of artificial intelligence (AI) in neurological biomarker development, and rising demand for personalized medicine.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Neurological Biomarker Market

The emerging trends within the neurological biomarker market exhibit advancements in technology, concepts of personalized medicine, and increasing research studies. Each of these may collectively usher in a paradigm shift in the formulation and application of biomarkers for neurological disorders, offering more diagnostic accuracy and treatment tailored to individual needs.

These emerging trends are reshaping the neurological biomarker market by improving diagnosis, extending personalized treatment options, and encouraging innovation through advanced technology coupled with collaborative research. The use of AI, improved imaging, and the concept of personalized medicine have become some of the most influential forces for change in this area, offering better management of neurological disorders.

Recent Developments in the Neurological Biomarker Market

The field of neurological disorders is experiencing significant growth, especially due to recent advancements in technological applications that have facilitated the integration of neurological biomarkers into the existing framework of diagnosis and treatment. There are three types of neurological disorder markers: proteins, genes, and imaging, which, when combined, provide key information about brain health and the progress of specific diseases. Given the trend showing an increase in neurodegenerative diseases such as Alzheimer's and Parkinson's, pattern biomarker identification will be emphasized, aimed at facilitating the early detection of diseases and personalized treatment for patients. From these changes, we expect to make great strides toward unraveling the mysteries surrounding many diverse neurological diseases and optimizing clinical management using enhanced diagnostic and therapeutic approaches.

Overall, these advances in neurological biomarkers bring a paradigm shift in terms of diagnosis and therapeutic interventions in neurological disorders. Thanks to novel biomarker capabilities and technologies, as well as genomic, microbiome, and digital advances, these innovations will facilitate early recognition, optimize patient care through personalized therapy, and enhance the treatment of neurological disorders in patients.

Strategic Growth Opportunities for Neurological Biomarker Market

Strategic growth opportunities in neurological biomarkers will emerge across several applications. These range from technological advancements to a focus on improving diagnostic and therapeutic approaches, offering the potential for further market expansion as well as the management of neurological disorders.

These strategic growth opportunities drive the neurological biomarkers market by encouraging innovative diagnostics and therapeutic approaches. The high emphasis on Alzheimer's, Parkinson's, multiple sclerosis, stroke, and neuroinflammation is fostering advancements toward developing better biomarkers associated with personalized treatment options, with a view to improving neurological disorder management.

Neurological Biomarker Market Driver and Challenges

There are a few key drivers and challenges that impact the neurological biomarker market. Technological advancements, economic factors, and regulatory considerations can significantly affect market dynamics. While the drivers support growth and innovation, challenges related to cost, regulation, and technology integration must be overcome to fully realize the potential of neurological biomarkers.

The factors responsible for driving the neurological biomarker market include:

Challenges in the neurological biomarker market include:

The drivers and challenges that influence the neurological biomarker market highlight the complexity of emerging technologies, cost and regulatory issues, and market access. While technological advancements and increased investment spur growth, various challenges related to technology, regulation, and integration impede the full realization of neurological biomarkers and their value addition to patient care.

List of Neurological Biomarker Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies neurological biomarker companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the neurological biomarker companies profiled in this report include-

Neurological Biomarker by Segment

The study includes a forecast for the global neurological biomarker by type, application, end use, and region.

Neurological Biomarker Market by Type [Analysis by Value from 2018 to 2030]:

Neurological Biomarker Market by Application [Analysis by Value from 2018 to 2030]:

Neurological Biomarker Market by End Use [Analysis by Value from 2018 to 2030]:

Neurological Biomarker Market by Region [Analysis by Value from 2018 to 2030]:

Country Wise Outlook for the Neurological Biomarker Market

The neurological biomarkers market has been undergoing significant changes in recent times, driven by technological innovations and a growing focus on precision medicine. These developments enhance diagnosis and management capabilities for neurological disorders. Established markets such as the United States, China, Germany, India, and Japan have witnessed key research, diagnostics, and treatments.

Features of the Global Neurological Biomarker Market

Market Size Estimates: Neurological biomarker market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Neurological biomarker market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Neurological biomarker market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, end use, and regions for the neurological biomarker market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the neurological biomarker market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

Table of Contents

1. Executive Summary

2. Global Neurological Biomarker Market : Market Dynamics

3. Market Trends and Forecast Analysis from 2018 to 2030

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

5. Competitor Analysis

6. Growth Opportunities and Strategic Analysis

7. Company Profiles of Leading Players

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â